Posted on Leave a comment

Idiopathic Pulmonary Fibrosis Treatment Market Size (7MM) was ~USD 3,300 million in 2023 and is projected to increase by 2034, estimates DelveInsight

DelveInsight’s report titled “Idiopathic Pulmonary Fibrosis Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of burns, historical and forecasted epidemiology, as well as the Idiopathic Pulmonary Fibrosis therapeutics market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan. Unlock key insights into […]

Posted on Leave a comment

Gavriel Dardashti Details Ibogaine Protocol Enhancements, Joined by Neuroscientist Misty Huckabey, at 2025 Denver Psychedelic Conference

PLANTATION, FL – April 30, 2025 – Representing Ibogaine by David Dardashti, Gavriel Dardashti will detail significant neuroscientific advancements enhancing ibogaine therapy protocols at the influential 2025 Psychedelic Conference in Denver, Colorado. Building on the foundational work of his father, founder David Dardashti, the presentation showcases how sophisticated technology refines and personalizes treatment, marking a […]

Posted on Leave a comment

Dry Eye Disease Treatment Market 2034: EMA, PDMA, FDA Approvals, Clinical Trials, Medication, Therapies, NICE Approvals, Prevalence, and Companies by DelveInsight

Dry Eye Disease Treatment Market Dry Eye Disease Companies are Palatin Technologies, Inc., Aldeyra Therapeutics, Inc., ReGenTree/RegeneRx Biopharmaceuticals, Inc., Mimetogen, Alcon/Aerie Pharmaceuticals, BRIM Biotechnology, Inc., Seikagaku Corporation, Mitotech, Senju Pharmaceutical, Sylentis, S.A./PharmaMar, Stuart Therapeutics, VivaVision Biotech, HanAll BioPharma Co., Ltd./Daewoong Pharmaceutical Co. Ltd., Redwood Pharma AB, AxeroVision, OKYO Pharma, AxeroVision, AxeroVision., Glaukos Corporation, Oculis, and […]

Posted on Leave a comment

Idiopathic Inflammatory Myositis Market is Projected to Grow at a CAGR of 21.1% by 2034 | DelveInsight

Idiopathic Inflammatory Myositis Market The idiopathic inflammatory myositis treatment market is poised for significant expansion, driven by the introduction of innovative targeted therapies and increasing disease awareness. Key idiopathic inflammatory myositis companies, including Octapharma, Pfizer, Mitsubishi Tanabe Pharma, AstraZeneca, Priovant Therapeutics, and CSL, among others, are advancing the treatment landscape with promising therapies, addressing the […]

Posted on Leave a comment

Allergic Conjunctivitis Clinical Trials Analysis 2025: EMA, PDMA, FDA Approvals, Medication, Therapies, NICE Approvals, Mechanism of Action, ROA, IND, NDA Approval and Companies by DelveInsight

Allergic Conjunctivitis Clinical Trials Allergic Conjunctivitis companies are OKYO Pharma, RAPT Therapeutics, Allakos, Sylentis, Postbiotica, Stuart Therapeutics, Oyster Point Pharma, Bausch Health Companies Inc., Bausch & Lomb Incorporated, Aldeyra Therapeutics, Vanda Pharmaceuticals, Noveome Biotherapeutics, Allakos, Inc., Regeneron Pharmaceuticals, Marinomed Biotech AG, Eleusis Holdings Ltd, IACTA Pharmaceuticals, JW Pharmaceutical, Nanomerics, Marinomed Biotech AG, ILTOO Pharma, Emergo […]

Posted on Leave a comment

Blue Sky Scrubs Celebrates International Women’s Day with a Special Giveaway Honoring Women in Healthcare

Blue Sky Scrubs celebrates International Women’s Day 2025 in Austin, Texas. This International Women’s Day, Blue Sky Scrubs is honoring the incredible women who lead, inspire, and heal within the healthcare community. In celebration of women’s achievements and contributions to medicine, the luxury scrub apparel brand is launching a special giveaway to recognize and uplift […]

Posted on Leave a comment

Niemann Pick C Disease Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies

DelveInsight’s “Niemann Pick C Disease Pipeline Insight 2025” report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Niemann Pick C Disease pipeline landscape. It covers the Niemann Pick C Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, […]

Posted on Leave a comment

Plantar Fasciitis Pipeline Analysis, Clinical Trials, 2025 | Plantar Fasciitis Treatment Market by DelveInsight | Mimedx, Revance Therapeutics

Plantar Fasciitis Pipeline Insights, 2025 Plantar Fasciitis Pipeline constitutes 3+ key companies continuously working towards developing 3+ Plantar Fasciitis treatment therapies, analyzes DelveInsight. Plantar Fasciitis Disease Overview: Plantar fasciitis is one of the most common reasons for heel pain. The plantar fascia is a thick, web-like ligament that links the heel bone to the front […]

Posted on Leave a comment

Bullous Keratopathy Market Poised for Robust Growth at an 11.5% CAGR Over the Coming Decade | DelveInsight

The bullous keratopathy treatment market is projected to experience substantial growth over the coming decade, driven by an aging population, increasing prevalence of cataract surgeries, glaucoma procedures, and novel pharmaceutical interventions by key bullous keratopathy players such as Aurion Biotechnologies, Emmecell, Trefoil Therapeutics, and Cellusion, among others. DelveInsight’s “Bullous Keratopathy Market Insights, Epidemiology, and Market […]

Posted on Leave a comment

Mantle Cell Lymphoma Clinical Trials Analysis 2025: EMA, PDMA, FDA Approvals, Medication, Therapies, NICE Approvals, Mechanism of Action, ROA, IND, NDA Approval and Companies by DelveInsight

Mantle Cell Lymphoma Clinical Trials Leading mantle cell lymphoma companies are BeiGene, Traws Pharm, Janssen/Pharmacyclics, LegoChem Biosciences, Incyte Corporation, Advenchen Laboratories, Merck & Co, Eternity Bioscience, Adicet Bio, Guangzhou Lupeng Pharmaceutical Company, AbbVie, InnoCare Pharma Inc., TG Therapeutics, Xynomic Pharmaceuticals, Nurix, and others. (Albany, USA) DelveInsight’s, “Mantle Cell Lymphoma Pipeline Insight, 2025,” report provides comprehensive […]